Skip to main content
Smart Investors Daily
Kenvue Inc. logo

NYSE · KVUE

Kenvue Inc.

Consumer Defensive · Household & Personal Products

$17.73

Down-$0.03 (-0.17%)

Updated Oct 9, 2026, 10:26 PM

SID Score

5.7/10

Composite research score

Smart Money

58/100

Neutral

Market cap
33.2B
P/E ratio
23.19
Dividend yield
4.66%
52-week range
$16.56 – $20.13
Volume
23.27M
Avg. volume
40.52M

Price performance · KVUE

KVUE price history

1M range · 21 trading sessions · Daily adjusted prices

Prices through Oct 8, 2026

KVUE closed at $17.73 after 21 trading sessions, down 0.34% for the selected period.

Last close
$17.73
Period change
-0.34%
Period low
$17.20
Period high
$17.92
Daily close
View OHLC price history
KVUE OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Oct 8, 2026$17.58$17.74$17.44$17.7323.27M
Oct 7, 2026$17.62$17.69$17.52$17.5311.88M
Oct 6, 2026$17.46$17.645$17.41$17.5910.87M
Oct 5, 2026$17.24$17.405$17.165$17.3913.93M
Oct 2, 2026$17.33$17.38$17.1614$17.2014M
Oct 1, 2026$17.43$17.545$17.19$17.2222.21M
Sep 30, 2026$18.08$18.08$17.66$17.6625.41M
Sep 29, 2026$17.74$17.93$17.7001$17.9119.19M
Sep 28, 2026$17.73$17.90$17.65$17.8816.03M
Sep 25, 2026$17.59$17.84$17.555$17.8012.58M
Sep 24, 2026$17.77$17.88$17.61$17.6117.49M
Sep 23, 2026$17.84$17.90$17.64$17.6716.17M
Sep 22, 2026$17.95$17.986$17.84$17.8614.29M
Sep 21, 2026$17.63$17.73$17.49$17.6725.68M
Sep 18, 2026$17.80$17.97$17.76$17.8126.72M
Sep 17, 2026$17.98$18.10$17.78$17.8723.45M
Sep 16, 2026$17.99$18.055$17.7601$17.8323.06M
Sep 15, 2026$17.93$17.9356$17.70$17.9253.83M
Sep 14, 2026$17.91$18.20$17.87$17.9140.65M
Sep 11, 2026$17.90$17.965$17.60$17.7847.16M
Sep 10, 2026$17.75$17.9158$17.72$17.7964.38M

Latest KVUE news

The latest Smart Investors Daily articles mentioning KVUE.

KVUE research

Overview

Company profile and research snapshot.

Company profile

Kenvue is the world's largest pure-play consumer health company by sales, generating over $15 billion in annual revenue. Formerly known as Johnson & Johnson's consumer segment, Kenvue spun off and went public in May 2023. It operates in a variety of categories within consumer health, such as cough, cold and allergy care, pain management, face and body care, and oral care, as well as women's health. Its portfolio has some of the most well-known brands in the space, including Tylenol, Listerine, Johnson's, Aveeno, and Neutrogena. Kenvue announced November 2025 that it signed a deal to be fully acquired by Kimberly-Clark with the deal expected to close during the second half of 2026.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
—
Average target
$18.57
Implied upside
—
Analysts
—
KVUE recent ratings
DateFirmRatingTarget
Aug 11, 2026UBSNeutral—
Jul 21, 2026BarclaysEqual-Weight—
Jul 16, 2026UBSNeutral—
Apr 15, 2026CitigroupNeutral—
Apr 14, 2026BarclaysEqual-Weight—
Open full forecast

News briefing

No generated briefing is available yet.

Yahoo · Oct 1, 2026

Kenvue (KVUE) Stock Still Appears 41% Undervalued On Cash Flow

Kenvue has delivered a 16.1% gain over the past year, even as shorter term returns have been softer. This puts fresh focus on whether the current share price lines up with the cash the business can generate over time. With the stock last closing at US$17.22, the question for investors is how much of Kenvue’s future cash flows are already reflected in that tag. The 16.1% return over the past 12 months puts recent buyers in profit and raises the issue of whether that move is fully supported by...

Yahoo · Oct 1, 2026

LISTERINE® Launches Oral Care Counts This World Smile Day as Oral Disease Cases Rise to 3.73 Billion

SUMMIT, N.J., October 01, 2026--Nearly half the world’s population is affected by oral disease – and the number of cases is rising. This World Smile Day, LISTERINE® is launching Oral Care Counts – a multiyear education and advocacy initiative showing why oral health is an essential part of overall health and how practical daily habits, including a three-step oral care routine of brushing, flossing and rinsing, can support better oral health. The multiyear education and advocacy campaign is desig

Yahoo · Sep 28, 2026

Kimberly-Clark Corporation Announces Commencement of Exchange Offers and Consent Solicitations for Kenvue Notes

Kimberly-Clark Corporation (NASDAQ: KMB) ("Kimberly-Clark") announced today the commencement, in connection with its previously announced pending acquisition ("Acquisition") of Kenvue Inc. (NYSE: KVUE) ("Kenvue"), of an exchange offer (each an "Exchange Offer" and, collectively, the "Exchange Offers") for any and all outstanding notes (the "Kenvue Notes") issued by Kenvue for up to $7,000,000,000 aggregate principal amount of new notes to be issued by Kimberly-Clark (the "Kimberly-Clark Notes")

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.